A randomized controlled trial investigating the effects of celecoxib in patients with localized prostate cancer.

UNLABELLED: Cyclooxygenase-2 (COX-2) is associated with tumour promotion, inhibition of apoptosis, angiogenesis and metastasis. Celecoxib, a selective COX-2 inhibitor was investigated, in patients with clinically localized prostate cancer using immunohistochemistry. PATIENTS AND METHODS: Patients w...

詳細記述

書誌詳細
主要な著者: Sooriakumaran, P, Coley, H, Fox, S, Macanas-Pirard, P, Lovell, D, Henderson, A, Eden, C, Miller, P, Langley, SE, Laing, R
フォーマット: Journal article
言語:English
出版事項: 2009